A Phase 2A Study of TRC105 (With Option to Add Bevacizumab) in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN)
Phase of Trial: Phase II
Latest Information Update: 08 Nov 2016
At a glance
- Drugs Carotuximab (Primary)
- Indications Choriocarcinoma; Gestational trophoblastic disease
- Focus Therapeutic Use
- Sponsors TRACON Pharmaceuticals
- 01 Nov 2016 Status changed from not yet recruiting to recruiting.
- 11 May 2016 This trial is expected to initiate in the second half of 2016, according to a TRACON Pharmaceuticals media release.
- 12 Feb 2016 New trial record